BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31849877)

  • 1. Antimicrobial Efficacy of Indolicidin Against Multi-Drug Resistant Enteroaggregative
    Vergis J; Malik SS; Pathak R; Kumar M; Ramanjaneya S; Kurkure NV; Barbuddhe SB; Rawool DB
    Front Microbiol; 2019; 10():2723. PubMed ID: 31849877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting Lactoferricin (17-30) as a Potential Antimicrobial and Antibiofilm Candidate Against Multi-Drug-Resistant Enteroaggregative
    Vergis J; Malik SS; Pathak R; Kumar M; Ramanjaneya S; Kurkure NV; Barbuddhe SB; Rawool DB
    Front Microbiol; 2020; 11():575917. PubMed ID: 33072040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Galleria mellonella larval model to evaluate antibacterial efficacy of Cecropin A (1-7)-Melittin against multi-drug resistant enteroaggregative Escherichia coli.
    Vergis J; Malik SVS; Pathak R; Kumar M; Kurkure NV; Barbuddhe SB; Rawool DB
    Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33512501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Efficacy of Green Synthesized Nanosilver with Entrapped Cinnamaldehyde against Multi-Drug-Resistant Enteroaggregative
    Prasastha Ram V; Yasur J; Abishad P; Unni V; Purushottam Gourkhede D; Nishanth MAD; Niveditha P; Vergis J; Singh Malik SV; Kullaiah B; Kurkure NV; Ramesh C; Dufossé L; Rawool DB; Barbuddhe SB
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Indolicidin, Cecropin A (1-7)-Melittin (CAMA) and Their Combination Against Biofilm-Forming Multidrug-Resistant Enteroaggregative Escherichia coli.
    Vergis J; Malik SVS; Pathak R; Kumar M; Sunitha R; Barbuddhe SB; Rawool DB
    Probiotics Antimicrob Proteins; 2020 Jun; 12(2):705-715. PubMed ID: 31485973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial efficacy of Cecropin A (1-7)- Melittin and Lactoferricin (17-30) against multi-drug resistant Salmonella Enteritidis.
    Gourkhede DP; Bhoomika S; Pathak R; Yadav JP; Nishanth D; Vergis J; Malik SVS; Barbuddhe SB; Rawool DB
    Microb Pathog; 2020 Oct; 147():104405. PubMed ID: 32707313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial effects of Lactobacillus plantarum and Lactobacillus acidophilus against multidrug-resistant enteroaggregative Escherichia coli.
    Kumar M; Dhaka P; Vijay D; Vergis J; Mohan V; Kumar A; Kurkure NV; Barbuddhe SB; Malik SV; Rawool DB
    Int J Antimicrob Agents; 2016 Sep; 48(3):265-70. PubMed ID: 27451088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green Synthesized Silver Nanoparticles Using Lactobacillus Acidophilus as an Antioxidant, Antimicrobial, and Antibiofilm Agent Against Multi-drug Resistant Enteroaggregative Escherichia Coli.
    Abishad P; Vergis J; Unni V; Ram VP; Niveditha P; Yasur J; Juliet S; John L; Byrappa K; Nambiar P; Kurkure NV; Barbuddhe SB; Rawool DB
    Probiotics Antimicrob Proteins; 2022 Oct; 14(5):904-914. PubMed ID: 35715714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive investigation of the medicinal efficacy of antimicrobial fusion peptides expressed in probiotic bacteria for the treatment of pan drug-resistant (PDR) infections.
    Safarpour-Dehkordi M; Chabok O; Asgari M; Khademi R; Doosti A
    Arch Microbiol; 2024 Feb; 206(3):93. PubMed ID: 38329629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typical and Atypical Enteroaggregative
    Guerrieri CG; Pereira MF; Galdino ACM; Dos Santos ALS; Elias WP; Schuenck RP; Spano LC
    Front Microbiol; 2019; 10():1791. PubMed ID: 31456762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico molecular docking and in vitro antimicrobial efficacy of phytochemicals against multi-drug-resistant enteroaggregative Escherichia coli and non-typhoidal Salmonella spp.
    Abishad P; Niveditha P; Unni V; Vergis J; Kurkure NV; Chaudhari S; Rawool DB; Barbuddhe SB
    Gut Pathog; 2021 Jul; 13(1):46. PubMed ID: 34273998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic characterization of enteroaggregative Escherichia coli isolates from pediatric population in Pakistan.
    Khalil U; Younus M; Asghar N; Siddiqui F; Gómez-Duarte OG; Wren BW; Bokhari H
    APMIS; 2016 Oct; 124(10):872-80. PubMed ID: 27485156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility to antimicrobial agents of enteroaggregative Escherichia coli strains isolated from children with diarrhea].
    Sobieszczańska B; Kowalska-Krochmal B; Mowszet K; Pytrus T
    Przegl Epidemiol; 2003; 57(3):499-503. PubMed ID: 14682169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model.
    Yang H; Chen G; Hu L; Liu Y; Cheng J; Ye Y; Li J
    J Microbiol Immunol Infect; 2018 Feb; 51(1):70-75. PubMed ID: 26906264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lectin Complement Pathway Is Involved in Protection Against Enteroaggregative
    Adler Sørensen C; Rosbjerg A; Hebbelstrup Jensen B; Krogfelt KA; Garred P
    Front Immunol; 2018; 9():1153. PubMed ID: 29896194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Resistance to Quinolones and β-Lactam Antibiotics in Enteroaggregative and Enterotoxigenic
    Guiral E; Gonçalves Quiles M; Muñoz L; Moreno-Morales J; Alejo-Cancho I; Salvador P; Alvarez-Martinez MJ; Marco F; Vila J
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibacterial activity and mechanism of a novel peptide MR-22 against multidrug-resistant
    Tian C; Zhao N; Yang L; Lin F; Cai R; Zhang Y; Peng J; Guo G
    Front Cell Infect Microbiol; 2024; 14():1334378. PubMed ID: 38328670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of enteroaggregative Escherichia coli among food handlers in three areas of Kenya: a possible transmission route of travelers' diarrhea.
    Oundo JO; Kariuki SM; Boga HI; Muli FW; Iijima Y
    J Travel Med; 2008; 15(1):31-8. PubMed ID: 18217867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAM-1: an antimicrobial peptide with promise against ceftazidime-avibactam resistant
    Han Y; Zhang Y; Zhang X; Huang Z; Kong J; Wang X; Chen L; Wang Y; Cao J; Zhou T; Shen M
    Front Microbiol; 2024; 15():1291876. PubMed ID: 38765679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteroaggregative Escherichia coli: an emerging enteric pathogen.
    Huang DB; Okhuysen PC; Jiang ZD; DuPont HL
    Am J Gastroenterol; 2004 Feb; 99(2):383-9. PubMed ID: 15046233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.